Table 2 Baseline participant characteristics
Run-in period | Main trial | |||
|---|---|---|---|---|
Number of patients (%) | Number of patients (%) | |||
Usual care | PhysioDirect | Usual care | PhysioDirect | |
N = 488 | N = 977 | N = 743 | N = 1506 | |
Agea | 49.8 (15.9) | 50.3 (16.0) | 49.0 (16.3) | 48.9 (16.0) |
Gender: | ||||
Female | 288 (59.0) | 583 (59.7) | 438 (59.0) | 897 (59.6) |
Male | 200 (41.0) | 394 (40.3) | 305 (41.1) | 609 (40.4) |
Referral problem: | ||||
Cervical | 63 (13.0) | 116 (11.9) | 89 (12.0) | 185 (12.3) |
Thoracic | 6 (1.2) | 19 (1.9) | 13 (1.8) | 35 (2.3) |
Lumbar | 139 (28.6) | 292 (29.9) | 203 (27.4) | 412 (27.4) |
Upper limb | 104 (21.4) | 201 (20.6) | 174 (23.5) | 351 (23.3) |
Lower limb | 147 (30.3) | 302 (30.9) | 225 (30.3) | 450 (29.9) |
Widespread pain | 3 (0.6) | 5 (0.5) | 7 (0.9) | 8 (0.5) |
Multiple MSK | 22 (4.5) | 39 (4.0) | 27 (3.6) | 55 (3.7) |
Other MSK | 2 (0.4) | 3 (0.3) | 4 (0.5) | 10 (0.7) |
PCT: | ||||
A | 128 (26.2) | 256 (26.2) | 251 (33.8) | 499 (33.1) |
B | 118 (24.2) | 224 (22.9) | 165 (22.2) | 348 (23.1) |
C | 159 (32.6) | 342 (35.0) | 174 (23.4) | 353 (23.4) |
D | 83 (17.0) | 155 (15.9) | 153 (20.6) | 306 (20.3) |